Atalanta Therapeutics’ Post

🎬 That's a wrap on day 3 of #ASCO24! 🔍 Catch up on the conference's breakthroughs and insights here:

Counting down to #TxSCO2024 in San Antonio! Excited to be speaking at the Texas Society of Clinical Oncology Annual Conference in San Antonio on September 20 and 21, 2024. Some of the topics being covered: - Policy & Legislative Updates - State of Oncology Update from ASCO President Robin Zon, MD - Clinical Applications of AI - Clinical Trial Diversity - Updates in Metastatic Breast Cancer - Gastrointestinal Cancer - Clinical Wellbeing - Cybersecurity - Nurse Navigation Register here: https://loom.ly/CTLgMY0 #Oncology #CancerCare #BiggerinTexas

CBeyond(TM) will assess nimacimab’s ability to safely induce weight loss, and will also evaluate a combination of a GLP-1 receptor agonist plus nimacimab. Read the full article here: https://bit.ly/3T0hw8H

Anzenna is heading to HOU.SEC.CON.! Our team is thrilled to connect with industry peers and share how our groundbreaking insider risk platform is transforming cybersecurity landscapes. 🔍 What sets Anzenna apart? We're dedicated to identifying both malicious and non-malicious insider threats, ensuring comprehensive security for your organization. Whether you're looking to bolster your defenses or curious about our unique capabilities, we'd love to chat! 🤝 Interested in learning more? We’re scheduling meetings throughout the conference. Send us a direct message to secure a time slot with our experts. This is a fantastic opportunity to dive deep into how Anzenna can tailor security solutions for your specific needs. 📅 See you at HouSecCon! #HouSecCon #CyberSecurity #InsiderRisk #Anzenna

During this year's Capital (Капитал) healthcare forum, Georgi Slavchev (HTA Ltd. ) delivered one of the most compelling presentations.  One aspect was the importance of biomarker tests in oncolcogy , noting that a €5.4 million investment by the Bulgarian healthcare system could potentially yield over €75 million in benefits to Bulgaria's GDP. Another crucial aspec addresses whether the higher costs for modern oncology therapies are justified: - Lung cancer could see a €17.1 million benefit in Bulgaria's GDP. - Melanoma could contribute €63.3 million to Bulgaria's GDP. - Breast cancer might add €40 million to Bulgaria's GDP. - Cervical cancer could result in a €33.8 million increase in Bulgaria's GDP. https://lnkd.in/dx4cS2Bq

📢 Biomolecules and Biomedicine Issue Vol. 24 No. 5 (October 2024) is now released! 😊 Apart from interesting original and narrative reviews, we further expand our article coverage with systematic reviews with/without meta-analysis. We also published a special article in this issue discussing a recent discovery of a new pathogen called Streptococcus anginosus that may be involved in gastritis and gastric cancer. Check out the issue here: https://lnkd.in/dmm_sQ9C #biomoleculesandbiomedicine #biomolbiomed #newissue #journal #biomedicaljournal #openaccessjournal #octoberissue #medicine #research #streptococcusanginosus #gastritis #gastriccancer

❓ Need to get caught up on all the info from day 4 of #ASCO24? 👉 Explore the conference's latest advancements and key insights here:

DNA repair and autophagy. We also provided some evidence about the importance of autophagy in this process: https://lnkd.in/dGBgAgBy